US 8242085
Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8242085 (Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer) held by BioCryst Pharmaceuticals, Inc. expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P31/16, A61P31/18